Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 10Insulin Resistance 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Diabetes Mellitus, Type 2 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Leukemia, Myeloid, Chronic-Phase 2Carotid Intimal Medial Thickness 1 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Neoplasm Metastasis 1Multiple Myeloma 1Metabolic Syndrome 1Meningioma 1Memory Disorders 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Acute 1Inflammation 1Hyperinsulinism 1Glucose Intolerance 1Glioblastoma 1Cognitive Dysfunction 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Pioglitazone 4Sitagliptin Phosphate 3Resistance Training 3Vildagliptin 2Sulfonylurea Compounds 2Nutritional Status 2Metformin 2Dipeptidyl-Peptidase IV Inhibitors 2Blood Specimen Collection 2voglibose 1saxagliptin 1repaglinide 1miglitol 1metahexamide 1meglitinide 1mazdutide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1alogliptin 1Urine Specimen Collection 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sodium-Glucose Transporter 2 Inhibitors 1Rosiglitazone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Type 2 × Pioglitazone × Clear all
NCT05098327 2023-08-15

Pioglitazone and Insulin Resistance in ADT

State University of New York at Buffalo

Phase 3 Withdrawn
Genitourinary

Diabetes Mellitus, Type 2, Insulin Resistance, Prostatic Neoplasms

NCT01935466 2022-01-25

PROBE-PIO

Post Graduate Institute of Medical Education and Research, Chandigarh

Completed
6,107 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus, Type 2

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡